| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/15/2010 | US20100093658 Therapeutic Agent For Metabolic Syndrome and Food Containing the Therapeutic Agent |
| 04/15/2010 | US20100093657 Low glycemic mixtures |
| 04/15/2010 | US20100093656 Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents |
| 04/15/2010 | US20100093655 Use of riluzole and derivatives thereof for producing new drugs |
| 04/15/2010 | US20100093654 Tetrasubstituted clucopyranosylated benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 04/15/2010 | US20100093653 Use of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-alpha-D-mannopyranosyl-oxy)-phenyl] hexane for the preparation of cosmetic compositions |
| 04/15/2010 | US20100093652 Preservative System for Emulsion-Based Therapeutic Topical Formulations |
| 04/15/2010 | US20100093651 Artemisinin Derivatives |
| 04/15/2010 | US20100093650 Pharmaceutical Anit-Infective Composition for Inhalation |
| 04/15/2010 | US20100093649 Synthetic glycolipid analogues and derivatives for the treatment of pathologic disorders |
| 04/15/2010 | US20100093648 Treatment of macular degeneration-related disorders |
| 04/15/2010 | US20100093647 Mgmt inhibitor combination for the treatment of neoplastic disorders |
| 04/15/2010 | US20100093638 Treament for chemical substance addiction |
| 04/15/2010 | US20100093634 Methods for regulating urinary potassium |
| 04/15/2010 | US20100093626 Peptide and small molecule agonists of epha and their uses in disease |
| 04/15/2010 | US20100093617 Use |
| 04/15/2010 | US20100093614 Novel Composition for Tumor Growth Control |
| 04/15/2010 | US20100093613 Methods for identifying agents and their use for the prevention or stabilization of fibrosis |
| 04/15/2010 | US20100093611 Compounds and methods for treating or preventing autoimmune diseases |
| 04/15/2010 | US20100093609 Prodrugs of triciribine and triciribine phosphate |
| 04/15/2010 | US20100093605 Peptides, derivatives and analogs thereof, and methods of using same |
| 04/15/2010 | US20100093603 Use of organic compounds |
| 04/15/2010 | US20100093601 Compositions and methods to protect cells by blocking entry of pathogen proteins |
| 04/15/2010 | US20100093600 Regulation of neurotransmitters sequestration and release through manipulation of the vesicular functions |
| 04/15/2010 | US20100092616 Method of producing a nicotine composition |
| 04/15/2010 | US20100092579 Medicament for treating lung cancer |
| 04/15/2010 | US20100092578 Protein kinase c iota |
| 04/15/2010 | US20100092570 Controlled release oxycodone compositions |
| 04/15/2010 | US20100092569 Product based on conjugated linoleic acid and a method for the manufacture thereof |
| 04/15/2010 | US20100092568 Drug microparticles |
| 04/15/2010 | US20100092566 Highly concentrated drug particles, formulations, suspensions and uses thereof |
| 04/15/2010 | US20100092565 Pharmaceutical composition comprising microparticle oily suspension |
| 04/15/2010 | US20100092563 Methods for the Preparation of Biologically Active Compounds in Nanoparticulate Form |
| 04/15/2010 | US20100092560 Reduced coenzyme q10-containing particulate composition and method for producing the same |
| 04/15/2010 | US20100092559 Boldine compounds for promoting bone growth |
| 04/15/2010 | US20100092557 Dosage Form Comprising Immediate Release Naproxen and Sustained Release Opioid Analgesic |
| 04/15/2010 | US20100092556 Alfuzosin formulations, methods of making, and methods of use |
| 04/15/2010 | US20100092555 Soft tablet containing high molecular weight cellulosics |
| 04/15/2010 | US20100092554 Combination with an extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
| 04/15/2010 | US20100092553 anti-misuse microparticulate oral pharmaceutical form |
| 04/15/2010 | US20100092552 Low dose controlled release tablet |
| 04/15/2010 | US20100092551 Solid preparation comprising alogliptin and pioglitazone |
| 04/15/2010 | US20100092549 Dosage Form Containing Two or More Active Pharmaceutical Ingredients in Different Physical Forms |
| 04/15/2010 | US20100092547 Compositions and methods for preventing and treating mucositis and weight loss |
| 04/15/2010 | US20100092546 Topical and Transdermal Delivery of HIF-1 Modulators to Prevent and Treat Chronic Wounds |
| 04/15/2010 | US20100092545 Polyethylene-oxide based films and drug delivery systems made therefrom |
| 04/15/2010 | US20100092543 Dimpled adhering troche for use on teeth or orthodontic braces |
| 04/15/2010 | US20100092542 Compositions and methods for treatment of eye disorders |
| 04/15/2010 | US20100092541 Compositions and methods for treatment of eye disorders |
| 04/15/2010 | US20100092540 Drug delivery compositions and medical devices containing block copolymer |
| 04/15/2010 | US20100092534 Combination Local Delivery Using a Stent |
| 04/15/2010 | US20100092533 Bioabsorbable Surgical Composition |
| 04/15/2010 | US20100092528 Fructan-based epilatory compositions |
| 04/15/2010 | US20100092526 Nanoemulsion therapeutic compositions and methods of using the same |
| 04/15/2010 | US20100092525 Medical device |
| 04/15/2010 | US20100092523 Molecules and methods for treatment and detection of cancer |
| 04/15/2010 | US20100092509 Hypo- and Hyper- Acetylated Meningococcal Capsular Saccharides |
| 04/15/2010 | US20100092496 drug-ligand conjugates that are potent cytotoxins; stabilized therapeutic agents and markers; exhibit high specificity of action, reduced toxicity, and improved stability in blood ; antitumors |
| 04/15/2010 | US20100092490 Method for assay on the effect of vascularization inhibitor |
| 04/15/2010 | US20100092488 Method for Treatment or Prevention of Disease Associated Wtih Functional Disorder of Regulatory T Cell |
| 04/15/2010 | US20100092486 Modulation of myeloid differentation primary response gene 88 (myd88) expression by antisense oligonucleotides |
| 04/15/2010 | US20100092481 Human cytomegalovirus neutralising antibodies and use thereof |
| 04/15/2010 | US20100092479 Compositions and methods for treatment of viral diseases |
| 04/15/2010 | US20100092478 Materials and methods for evaluating and treating neuromyelitis optica (nmo) |
| 04/15/2010 | US20100092477 Methods and compositions for treating prostate cancer |
| 04/15/2010 | US20100092474 Pharmaceutical combinations |
| 04/15/2010 | US20100092469 Antagonists of a non-selective cation channel in neural cells |
| 04/15/2010 | US20100092467 Prevention of tissue ischemia, related methods and compositions |
| 04/15/2010 | US20100092463 Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject |
| 04/15/2010 | US20100092459 Protein Complex and Uses |
| 04/15/2010 | US20100092456 Methods of treatment |
| 04/15/2010 | US20100092454 novel use of antidepressant compounds and related compositions |
| 04/15/2010 | US20100092453 Method of producing porous microparticles |
| 04/15/2010 | US20100092448 Local control of inflammation |
| 04/15/2010 | US20100092446 Drug solution having reduced dissolved oxygen content, method of producing the same and drug solution containing unit having reduced dissolved oxygen content |
| 04/15/2010 | US20100092443 Novel combinations of nitrogenated heterocyclic antibacterial compounds with other antibacterial compounds and the use of same as drugs |
| 04/15/2010 | US20100092427 Pyridinone Diketo Acids: Inhibitors of HIV Replication in Combination Therapy |
| 04/15/2010 | US20100092426 2-substituted benzimidazoles |
| 04/15/2010 | US20100092425 Nicotine Immunonanotherapeutics |
| 04/15/2010 | US20100092422 Poly (ß-hydroxy short-medium chain fatty acid) |
| 04/15/2010 | US20100092421 Process for the Preparation of Sevelamer Hydrochloride and Formulation Thereof |
| 04/15/2010 | US20100092419 Magnetic fluids and their use |
| 04/15/2010 | US20100092406 Systems, Methods, and Compositions for Treatment and Use of a Palatal Patch |
| 04/15/2010 | US20100092405 Polyamino acid derivatives and use thereof in compositions for treating keratin fibers |
| 04/15/2010 | US20100092403 aerosol sprays; fast onset of effect |
| 04/15/2010 | US20100092402 Treatment of respiratory disease |
| 04/15/2010 | US20100092401 Immune response modifier formulations |
| 04/15/2010 | US20100092400 Salicylic Acid Composition |
| 04/15/2010 | US20100092398 Antimicrobial compositions and applications therefore |
| 04/15/2010 | US20100092388 Anthracycline Derivatives |
| 04/15/2010 | US20100092386 System for delivering therapeutic agents into living cells and cells nuclei |
| 04/15/2010 | US20100092385 Novel Heteroaryl Substituted Imidazo [1,2-A] Pyridine Derivatives |
| 04/15/2010 | US20100089840 Removal of Adenine During A Pathogen Reduction Process in Whole Blood or Red Blood Cells by Dilution |
| 04/15/2010 | DE4315525B4 Pharmazeutische Zusammensetzung Pharmaceutical composition |
| 04/15/2010 | DE102008050957A1 New ecdysone compounds useful for treating age-related diseases such as osteoporosis, osteoarthritis, incontinence, obesity, arteriosclerosis, hypertonus, metabolic syndrome, anemias, hyperandrogenemia, cellulite and menopausal hot flushes |
| 04/15/2010 | DE102008050597A1 Preparation, useful for treating and preventing idiopathic sudden sensorineural hearing loss, comprises pentaerythritol tetra-, pentaerythritol trinitrate, pentaerythritol dinitrate or pentaerythritol mononitrate, and an excipient |
| 04/15/2010 | DE102008050591A1 Beverage, useful to promote dental health of children, comprises sugar-free teas, e.g. rooibos tea, and sugar substitute, e.g. xylitol, which inhibits growth of cariogenic microorganisms |
| 04/15/2010 | DE102008047743A1 Verwendung von Harnstoff-Derivaten und Phenacylthiazolium-Salzen zur Behandlung von Körpergeruch The use of urea derivatives and Phenacylthiazolium salts for the treatment of body odor |
| 04/15/2010 | DE102008047128A1 Verwendung von cis-Imidazolinen, insbesondere Nutlinen, zur Behandlung von chemoresistenten Krebserkrankungen Using cis-imidazolines, Nutlinen particular, for the treatment of chemoresistant cancer |
| 04/15/2010 | CA2776945A1 Methods and compositions for treating status epilepticus and seizures causing status epilepticus |